top of page

Drug Research

Mental health disorders are on the rise, and the treatments available are usually long-term and expensive, with side effects that often lead to relapse. Our team of PhDs in neuroscience has developed novel groundbreaking treatments for mental health disorders that are highly effective. Our treatments have been tested on mice and have shown a significant effects.

AdobeStock_424806330.jpeg

Portfolio

Novel Drug target for anxiety disorders - Preclinical

All anxiolytic drugs have high risk of addiction, low specificity and desensitization over time.  Our novel discovered drug target is specific, does not hold risk for addiction and the same low treatment dosage can be used long term.

Novel Drug for addiction and compulsive disorders - Preclinical

There is an urgent need for new treatments to help people with addiction and compulsive behaviours. With our novel drug treatment we can trigger neuroplasticity and long-term synaptic changes in the circuitry involved in addiction and compulsive behaviours.

Novel treatment/prevention for autism - Preclinical

Our company is developing a drug (also for prevention) for individuals with autism. The drug is made of a vitamin that has been shown to have therapeutic benefits in preclinical trials. 

Novel drug treatment for chronic pain - Preclinical

People are spending billions on painkillers, which have side effects and addictive properties. Our solution, an epigenetic drug for chronic pain, will change the game of chronic pain treatment. Based on our preclinical studies the drug will be non-addictive, but will provide relief from chronic pain.

bottom of page